1.
Lebwohl M, Kircik L, Moore A, Stein Gold L, Del Rosso J, Draelos Z, Gooderham M, Green L, Herbert A, Papp K, Bagel J, Bhatia N, Ferris L, Jones T, Kempers S, Pariser D, Yamauchi P, Zirwas M, Feng A, Burnett P, Higham R, Berk D. Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin [Internet]. 2021Nov.5 [cited 2022May22];5(6):s42. Available from: https://www.jofskin.org/index.php/skin/article/view/1393